Top

Published in:

Open Access 01-08-2018 | Neurology and Preclinical Neurological Studies - Review Article

On the neuronal circuitry mediating l-DOPA-induced dyskinesia

Authors: M. Angela Cenci, Henrik Jörntell, Per Petersson

Published in: Journal of Neural Transmission | Issue 8/2018

Abstract

With the advent of rodent models of l-DOPA-induced dyskinesia (LID), a growing literature has linked molecular changes in the striatum to the development and expression of abnormal involuntary movements. Changes in information processing at the striatal level are assumed to impact on the activity of downstream basal ganglia nuclei, which in turn influence brain-wide networks, but very little is actually known about systems-level mechanisms of dyskinesia. As an aid to approach this topic, we here review the anatomical and physiological organisation of cortico-basal ganglia-thalamocortical circuits, and the changes affecting these circuits in animal models of parkinsonism and LID. We then review recent findings indicating that an abnormal cerebellar compensation plays a causal role in LID, and that structures outside of the classical motor circuits are implicated too. In summarizing the available data, we also propose hypotheses and identify important knowledge gaps worthy of further investigation. In addition to informing novel therapeutic approaches, the study of LID can provide new clues about the interplay between different brain circuits in the control of movement.

Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12(10):366–375PubMedCrossRef

Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson’s disease therapy. J Clin Invest 127(2):720–734. https://doi.org/10.1172/JCI90132 PubMedPubMedCentralCrossRef

Alegre M, Lopez-Azcarate J, Obeso I, Wilkinson L, Rodriguez-Oroz MC, Valencia M, Garcia-Garcia D, Guridi J, Artieda J, Jahanshahi M, Obeso JA (2013) The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson’s disease. Exp Neurol 239:1–12. https://doi.org/10.1016/j.expneurol.2012.08.027 PubMedCrossRef

Alonso-Frech F, Zamarbide I, Alegre M, Rodriguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA (2006) Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson’s disease. Brain 129(Pt 7):1748–1757. https://doi.org/10.1093/brain/awl103 PubMedCrossRef

Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson’s disease. Neurobiol Dis 6(6):461–474. https://doi.org/10.1006/nbdi.1999.0259 PubMedCrossRef

Baker PM, Jhou T, Li B, Matsumoto M, Mizumori SJ, Stephenson-Jones M, Vicentic A (2016) The lateral habenula circuitry: reward processing and cognitive control. J Neurosci 36(45):11482–11488. https://doi.org/10.1523/JNEUROSCI.2350-16.2016 PubMedPubMedCentralCrossRef

Bastide MF, Dovero S, Charron G, Porras G, Gross CE, Fernagut PO, Bezard E (2014) Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiol Dis 62:179–192. https://doi.org/10.1016/j.nbd.2013.09.020 PubMedCrossRef

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdere P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bezard E (2015) Pathophysiology of l-dopa-induced motor and non-motor complications in Parkinson’s disease. Prog Neurobiol 132:96–168. https://doi.org/10.1016/j.pneurobio.2015.07.002 PubMedCrossRef

Bastide MF, de la Crompe B, Doudnikoff E, Fernagut PO, Gross CE, Mallet N, Boraud T, Bezard E (2016) Inhibiting lateral habenula improves l-DOPA-induced dyskinesia. Biol Psychiatry 79(5):345–353. https://doi.org/10.1016/j.biopsych.2014.08.022 PubMedCrossRef

Bastide MF, Glangetas C, Doudnikoff E, Li Q, Bourdenx M, Fernagut PO, Dumont EC, Georges F, Bezard E (2017) Involvement of the bed nucleus of the stria terminalis in l-Dopa induced dyskinesia. Sci Rep 7(1):2348. https://doi.org/10.1038/s41598-017-02572-9 PubMedPubMedCentralCrossRef

Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P (2010) Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci USA 107(33):14845–14850. https://doi.org/10.1073/pnas.1009874107 PubMedCrossRef

Baufreton J, Atherton JF, Surmeier DJ, Bevan MD (2005) Enhancement of excitatory synaptic integration by GABAergic inhibition in the subthalamic nucleus. J Neurosci 25(37):8505–8517. https://doi.org/10.1523/JNEUROSCI.1163-05.2005 PubMedCrossRef

Belic JJ, Halje P, Richter U, Petersson P, Hellgren Kotaleski J (2016) Untangling cortico-striatal connectivity and cross-frequency coupling in l-DOPA-induced dyskinesia. Front Syst Neurosci 10:26. https://doi.org/10.3389/fnsys.2016.00026 PubMedPubMedCentralCrossRef

Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249(4975):1436–1438PubMedCrossRef

Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ (2002) Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25(10):525–531PubMedCrossRef

Bevan MD, Atherton JF, Baufreton J (2006) Cellular principles underlying normal and pathological activity in the subthalamic nucleus. Curr Opin Neurobiol 16(6):621–628. https://doi.org/10.1016/j.conb.2006.10.003 PubMedCrossRef

Bimpisidis Z, Oberg CM, Maslava N, Cenci MA, Lundblad C (2017) Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson’s disease. Exp Neurol 292:113–124. https://doi.org/10.1016/j.expneurol.2017.03.006 PubMedCrossRef

Bosch-Bouju C, Hyland BI, Parr-Brownlie LC (2013) Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions. Front Comput Neurosci 7:163. https://doi.org/10.3389/fncom.2013.00163 PubMedPubMedCentralCrossRef

Bostan AC, Dum RP, Strick PL (2010) The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci USA 107(18):8452–8456. https://doi.org/10.1073/pnas.1000496107 PubMedCrossRef

Brown P (2007) Abnormal oscillatory synchronisation in the motor system leads to impaired movement. Curr Opin Neurobiol 17(6):656–664. https://doi.org/10.1016/j.conb.2007.12.001 PubMedCrossRef

Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V (2001) Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson’s disease. J Neurosci 21(3):1033–1038PubMedCrossRef

Brusa L, Ceravolo R, Kiferle L, Monteleone F, Iani C, Schillaci O, Stanzione P, Koch G (2012) Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson’s disease patients. Parkinsonism Relat Disord 18(1):59–62. https://doi.org/10.1016/j.parkreldis.2011.08.019 PubMedCrossRef

Calabresi P, Giacomini P, Centonze D, Bernardi G (2000) Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol 47(4 Suppl 1):S60–S68 (discussion S68–69) PubMed

Calon F, Grondin R, Morissette M, Goulet M, Blanchet PJ, Di Paolo T, Bedard PJ (2000) Molecular basis of levodopa-induced dyskinesias. Ann Neurol 47(4 Suppl 1):S70–S78PubMed

Caparros-Lefebvre D, Blond S, Feltin MP, Pollak P, Benabid AL (1999) Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry 67(3):308–314PubMedPubMedCentralCrossRef

Carta M, Bezard E (2011) Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia. Neuroscience 198:245–251. https://doi.org/10.1016/j.neuroscience.2011.07.070 PubMedCrossRef

Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30(7):895–903. https://doi.org/10.1002/mds.26282 PubMedPubMedCentralCrossRef

Cenci MA (2007) Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia. Trends Neurosci 30(5):236–243. https://doi.org/10.1016/j.tins.2007.03.005 PubMedCrossRef

Cenci MA (2014) Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol 5:242. https://doi.org/10.3389/fneur.2014.00242 PubMedPubMedCentralCrossRef

Cenci MA, Crossman AR (2018) Animal models of l-DOPA-induced dyskinesia in Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.27337 PubMedCrossRef

Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M, Ponzo V, Picazio S, Passamonti L, Salsone M, Augimeri A, Caltagirone C, Quattrone A (2015) A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Brain 138(Pt 2):414–427. https://doi.org/10.1093/brain/awu329 PubMedCrossRef

Cerasa A, Obeso I, Dileone M, Quattrone A (2017) Transcranial non-invasive brain stimulation in Parkinson’s disease patients with dyskinesias. Where is the Optimal Target? Cerebellum 16(1):276–278. https://doi.org/10.1007/s12311-016-0768-y PubMedCrossRef

Chan V, Starr PA, Turner RS (2011) Bursts and oscillations as independent properties of neural activity in the parkinsonian globus pallidus internus. Neurobiol Dis 41(1):2–10. https://doi.org/10.1016/j.nbd.2010.08.012 PubMedCrossRef

Delaville C, McCoy AJ, Gerber CM, Cruz AV, Walters JR (2015) Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks. J Neurosci 35(17):6918–6930. https://doi.org/10.1523/JNEUROSCI.0587-15.2015 PubMedPubMedCentralCrossRef

DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281–285PubMedCrossRef

Dobbs LK, Kaplan AR, Lemos JC, Matsui A, Rubinstein M, Alvarez VA (2016) Dopamine regulation of lateral inhibition between striatal neurons gates the stimulant actions of cocaine. Neuron 90(5):1100–1113. https://doi.org/10.1016/j.neuron.2016.04.031 PubMedPubMedCentralCrossRef

Dumont EC (2009) What is the bed nucleus of the stria terminalis? Prog Neuropsychopharmacol Biol Psychiatry 33(8):1289–1290. https://doi.org/10.1016/j.pnpbp.2009.07.006 PubMedPubMedCentralCrossRef

Dupre KB, Dodge C, Delaville C, Brazhnik E, Novikov J, Walters JR (2015) Ventromedial thalamus is critical for expression of cortical narrowband high gamma oscillations but not l-DOPA-induced dyskinesia in hemiparkinsonian rats. Paper presented at the SFN Annual Meeting

Dupre KB, Cruz AV, McCoy AJ, Delaville C, Gerber CM, Eyring KW, Walters JR (2016) Effects of l-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson’s disease. Neurobiol Dis 86:1–15. https://doi.org/10.1016/j.nbd.2015.11.009 PubMedCrossRef

Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG (2007) Levodopa-induced dyskinesias. Movement Disord 22(10):1379–1389. https://doi.org/10.1002/mds.21475 PubMedCrossRef

Fasano S, Bezard E, D’Antoni A, Francardo V, Indrigo M, Qin L, Dovero S, Cerovic M, Cenci MA, Brambilla R (2010) Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with l-dopa-induced dyskinesia. Proc Natl Acad Sci USA 107(50):21824–21829. https://doi.org/10.1073/pnas.1012071107 PubMedCrossRef

Ferrucci R, Cortese F, Bianchi M, Pittera D, Turrone R, Bocci T, Borroni B, Vergari M, Cogiamanian F, Ardolino G, Di Fonzo A, Padovani A, Priori A (2016) Cerebellar and motor cortical transcranial stimulation decrease Levodopa-induced dyskinesias in Parkinson’s disease. Cerebellum 15(1):43–47. https://doi.org/10.1007/s12311-015-0737-x PubMedCrossRef

Fieblinger T, Cenci MA (2015) Zooming in on the small: the plasticity of striatal dendritic spines in l-DOPA-induced dyskinesia. Mov Disord 30(4):484–493. https://doi.org/10.1002/mds.26139 PubMedCrossRef

Fieblinger T, Graves SM, Sebel LE, Alcacer C, Plotkin JL, Gertler TS, Chan CS, Heiman M, Greengard P, Cenci MA, Surmeier DJ (2014) Cell type-specific plasticity of striatal projection neurons in parkinsonism and l-DOPA-induced dyskinesia. Nat Commun 5:5316. https://doi.org/10.1038/ncomms6316 PubMedPubMedCentralCrossRef

Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547(1):142–151PubMed

Filion M, Tremblay L, Bedard PJ (1991) Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547(1):152–161PubMed

Fogelson N, Pogosyan A, Kuhn AA, Kupsch A, van Bruggen G, Speelman H, Tijssen M, Quartarone A, Insola A, Mazzone P, Di Lazzaro V, Limousin P, Brown P (2005) Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson’s disease. Eur J Neurosci 22(1):257–266. https://doi.org/10.1111/j.1460-9568.2005.04179.x PubMedCrossRef

Galarreta M, Hestrin S (1999) A network of fast-spiking cells in the neocortex connected by electrical synapses. Nature 402(6757):72–75. https://doi.org/10.1038/47029 PubMedCrossRef

Galvan A, Villalba RM, Wichmann T, Smith Y (2016) The thalamostriatal system in normal and disease states. In: Steiner H, Tseng K (eds) Handbook of basal ganglia structure and function, vol 24, 2nd edn. Elsevier, Chennai, pp 477–493CrossRef

Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441–466. https://doi.org/10.1146/annurev-neuro-061010-113641 PubMedPubMedCentralCrossRef

Gibson JR, Beierlein M, Connors BW (1999) Two networks of electrically coupled inhibitory neurons in neocortex. Nature 402(6757):75–79. https://doi.org/10.1038/47035 PubMedCrossRef

Girasole AE, Lum MY, Nathaniel D, Bair-Marshall CJ, Guenthner CJ, Luo L, Kreitzer AC, Nelson AB (2018) A subpopulation of striatal neurons mediates Levodopa-induced dyskinesia. Neuron 97(4):787–795 e786. https://doi.org/10.1016/j.neuron.2018.01.017 PubMedCrossRef

Gittis AH, Hang GB, LaDow ES, Shoenfeld LR, Atallah BV, Finkbeiner S, Kreitzer AC (2011) Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. Neuron 71(5):858–868. https://doi.org/10.1016/j.neuron.2011.06.035 PubMedPubMedCentralCrossRef

Gittis AH, Berke JD, Bevan MD, Chan CS, Mallet N, Morrow MM, Schmidt R (2014) New roles for the external globus pallidus in basal ganglia circuits and behavior. J Neurosci 34(46):15178–15183. https://doi.org/10.1523/JNEUROSCI.3252-14.2014 PubMedPubMedCentralCrossRef

Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E (2005) Involvement of sensorimotor, limbic, and associative basal ganglia domains in l-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 25(8):2102–2107. https://doi.org/10.1523/JNEUROSCI.5059-04.2005 PubMedCrossRef

Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M (2008) L-dopa-induced dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurgery 62(2):311–323. https://doi.org/10.1227/01.neu.0000315998.58022.55 (discussion 323–315) PubMedCrossRef

Halje P, Tamte M, Richter U, Mohammed M, Cenci MA, Petersson P (2012) Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. J Neurosci 32(47):16541–16551. https://doi.org/10.1523/JNEUROSCI.3047-12.2012 PubMedCrossRef

Hazrati LN, Parent A (1991) Projection from the external pallidum to the reticular thalamic nucleus in the squirrel monkey. Brain Res 550(1):142–146PubMedCrossRef

Heiman M, Heilbut A, Francardo V, Kulicke R, Fenster RJ, Kolaczyk ED, Mesirov JP, Surmeier DJ, Cenci MA, Greengard P (2014) Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc Natl Acad Sci USA 111(12):4578–4583. https://doi.org/10.1073/pnas.1401819111 PubMedCrossRef

Hernandez FL, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R (2017) Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. Mov Disord 32(4):530–537. https://doi.org/10.1002/mds.2694 CrossRef

Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Lokkegaard A, Siebner HR (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 138(Pt 6):1658–1666. https://doi.org/10.1093/brain/awv096 PubMedPubMedCentralCrossRef

Herz DM, Haagensen BN, Nielsen SH, Madsen KH, Lokkegaard A, Siebner HR (2016) Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson’s disease. Mov Disord 31(4):521–529. https://doi.org/10.1002/mds.26540 PubMedPubMedCentralCrossRef

Hoshi E, Tremblay L, Feger J, Carras PL, Strick PL (2005) The cerebellum communicates with the basal ganglia. Nat Neurosci 8(11):1491–1493. https://doi.org/10.1038/nn1544 PubMedCrossRef

Jefferys JG, Traub RD, Whittington MA (1996) Neuronal networks for induced ‘40 Hz’ rhythms. Trends Neurosci 19(5):202–208PubMedCrossRef

Jones EG (2009) Synchrony in the interconnected circuitry of the thalamus and cerebral cortex. Ann N Y Acad Sci 1157:10–23. https://doi.org/10.1111/j.1749-6632.2009.04534.x PubMedCrossRef

Jorntell H (2017) Cerebellar physiology: links between microcircuitry properties and sensorimotor functions. J Physiol 595(1):11–27. https://doi.org/10.1113/JP272769 PubMedCrossRef

Jorntell H, Ekerot CF (1999) Topographical organization of projections to cat motor cortex from nucleus interpositus anterior and forelimb skin. J Physiol 514(Pt 2):551–566PubMedPubMedCentralCrossRef

Jourdain VA, Tang CC, Holtbernd F, Dresel C, Choi YY, Ma Y, Dhawan V, Eidelberg D (2016) Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. JCI Insight 1(15):e86615. https://doi.org/10.1172/jci.insight.86615 PubMedPubMedCentralCrossRef

Jouve L, Salin P, Melon C, Kerkerian-Le Goff L (2010) Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson’s disease. J Neurosci 30(29):9919–9928. https://doi.org/10.1523/JNEUROSCI.1404-10.2010 PubMedCrossRef

Kerkerian-Le Goff L, Jouve L, Melon C, Salin P (2009) Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson’s disease. Parkinsonism Relat Disord 15 (Suppl 3):S167–S170. https://doi.org/10.1016/S1353-8020(09)70807-7 PubMedCrossRef

Kishore A, Popa T, Balachandran A, Chandran S, Pradeep S, Backer F, Krishnan S, Meunier S (2014) Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson’s disease: clues from dyskinetic patients. Cereb Cortex 24(8):2055–2067. https://doi.org/10.1093/cercor/bht058 PubMedCrossRef

Kita H, Jaeger D (2016) Organisation of the globus pallidus. In: Steiner H, Tseng K (eds) Handbook of basal ganglia structure and function, vol 24, 2nd edn. Elsevier, Chennai, pp 259–276CrossRef

Koch G, Brusa L, Carrillo F, Lo Gerfo E, Torriero S, Oliveri M, Mir P, Caltagirone C, Stanzione P (2009) Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 73(2):113–119. https://doi.org/10.1212/WNL.0b013e3181ad5387 PubMedCrossRef

Koshimizu Y, Fujiyama F, Nakamura KC, Furuta T, Kaneko T (2013) Quantitative analysis of axon bouton distribution of subthalamic nucleus neurons in the rat by single neuron visualization with a viral vector. J Comp Neurol 521(9):2125–2146. https://doi.org/10.1002/cne.23277 PubMedCrossRef

Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, Deisseroth K, Kreitzer AC (2010) Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466(7306):622–626. https://doi.org/10.1038/nature09159 PubMedPubMedCentralCrossRef

Lanciego JL, Rodriguez-Oroz MC, Blesa FJ, Alvarez-Erviti L, Guridi J, Barroso-Chinea P, Smith Y, Obeso JA (2008) Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys. Mov Disord 23(5):708–715. https://doi.org/10.1002/mds.21906 PubMedPubMedCentralCrossRef

Lewis MM, Du G, Kidacki M, Patel N, Shaffer ML, Mailman RB, Huang X (2013) Higher iron in the red nucleus marks Parkinson’s dyskinesia. Neurobiol Aging 34(5):1497–1503. https://doi.org/10.1016/j.neurobiolaging.2012.10.025 PubMedCrossRef

Lindgren HS, Rylander D, Iderberg H, Andersson M, O’Sullivan SS, Williams DR, Lees AJ, Cenci MA (2011) Putaminal upregulation of FosB/DeltaFosB-like immunoreactivity in Parkinson’s disease patients with dyskinesia. J Parkinsons Dis 1(4):347–357. https://doi.org/10.3233/JPD-2011-11068 PubMedCrossRef

Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso JA (1992) Levodopa-induced dyskinesias in Parkinson’s disease: clinical and pharmacological classification. Mov Disord 7(2):117–124. https://doi.org/10.1002/mds.870070204 PubMedCrossRef

Magill PJ, Bolam JP, Bevan MD (2000) Relationship of activity in the subthalamic nucleus–globus pallidus network to cortical electroencephalogram. J Neurosci 20(2):820–833PubMedCrossRef

Mak MK, Wong-Yu IS, Shen X, Chung CL (2017) Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol 13(11):689–703. https://doi.org/10.1038/nrneurol.2017.128 PubMedCrossRef

Mallet N, Pogosyan A, Sharott A, Csicsvari J, Bolam JP, Brown P, Magill PJ (2008) Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 28(18):4795–4806. https://doi.org/10.1523/JNEUROSCI.0123-08.2008 PubMedCrossRef

Mallet N, Schmidt R, Leventhal D, Chen F, Amer N, Boraud T, Berke JD (2016) Arkypallidal cells send a stop signal to striatum. Neuron 89(2):308–316. https://doi.org/10.1016/j.neuron.2015.12.017 PubMedPubMedCentralCrossRef

Marsden CD, Obeso JA (1994) The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson’s disease. Brain 117(Pt 4):877–897PubMedCrossRef

Mastro KJ, Bouchard RS, Holt HA, Gittis AH (2014) Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways. J Neurosci 34(6):2087–2099. https://doi.org/10.1523/JNEUROSCI.4646-13.2014 PubMedPubMedCentralCrossRef

McCarthy MM, Moore-Kochlacs C, Gu X, Boyden ES, Han X, Kopell N (2011) Striatal origin of the pathologic beta oscillations in Parkinson’s disease. Proc Natl Acad Sci USA 108(28):11620–11625. https://doi.org/10.1073/pnas.1107748108 PubMedCrossRef

Minamimoto T, Kimura M (2002) Participation of the thalamic CM–Pf complex in attentional orienting. J Neurophysiol 87(6):3090–3101. https://doi.org/10.1152/jn.2002.87.6.3090 PubMedCrossRef

Moss J, Bolam JP (2008) A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 28(44):11221–11230. https://doi.org/10.1523/JNEUROSCI.2780-08.2008 PubMedCrossRef

Nagaeva DV, Akhmadeev AV (2006) Structural organization, neurochemical characteristics, and connections of the reticular nucleus of the thalamus. Neurosci Behav Physiol 36(9):987–995. https://doi.org/10.1007/s11055-006-0134-5 PubMedCrossRef

Nambu A, Tokuno H, Hamada I, Kita H, Imanishi M, Akazawa T, Ikeuchi Y, Hasegawa N (2000) Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 84(1):289–300PubMedCrossRef

Nicola SM, Surmeier J, Malenka RC (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23:185–215. https://doi.org/10.1146/annurev.neuro.23.1.185 PubMedCrossRef

Obeso JA, Jahanshahi M, Alvarez L, Macias R, Pedroso I, Wilkinson L, Pavon N, Day B, Pinto S, Rodriguez-Oroz MC, Tejeiro J, Artieda J, Talelli P, Swayne O, Rodriguez R, Bhatia K, Rodriguez-Diaz M, Lopez G, Guridi J, Rothwell JC (2009) What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson’s disease. Exp Neurol 220(2):283–292. https://doi.org/10.1016/j.expneurol.2009.08.030 PubMedCrossRef

Ohlin KE, Sebastianutto I, Adkins CE, Lundblad C, Lockman PR, Cenci MA (2012) Impact of l-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson’s disease. Neuroimage 61(1):228–239. https://doi.org/10.1016/j.neuroimage.2012.02.066 PubMedPubMedCentralCrossRef

Ohye C, Shibazaki T (2001) Lesioning the thalamus for dyskinesia. Stereotact Funct Neurosurg 77(1–4):33–39. https://doi.org/10.1159/000064589 PubMedCrossRef

Papa SM, Desimone R, Fiorani M, Oldfield EH (1999) Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 46(5):732–738PubMedCrossRef

Perez XA, Zhang D, Bordia T, Quik M (2017) Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 32(4):538–548. https://doi.org/10.1002/mds.26955 PubMedPubMedCentralCrossRef

Perez XA, Bordia T, Quik M (2018) The striatal cholinergic system in l-DOPA-induced dyskinesia. J Neural Transm. https://doi.org/10.1007/s00702-018-1845-9 CrossRefPubMed

Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P (2003) Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat Neurosci 6(5):501–506. https://doi.org/10.1038/nn1040 PubMedCrossRef

Plenz D, Kital ST (1999) A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400(6745):677–682. https://doi.org/10.1038/23281 PubMedCrossRef

Rajan R, Popa T, Quartarone A, Ghilardi MF, Kishore A (2017) Cortical plasticity and levodopa-induced dyskinesias in Parkinson’s disease: Connecting the dots in a multicomponent network. Clin Neurophysiol 128(6):992–999. https://doi.org/10.1016/j.clinph.2017.03.043 PubMedCrossRef

Rascol O, Sabatini U, Brefel C, Fabre N, Rai S, Senard JM, Celsis P, Viallard G, Montastruc JL, Chollet F (1998) Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia. Brain 121(Pt 3):527–533PubMedCrossRef

Redgrave P, Gurney K, Reynolds J (2008) What is reinforced by phasic dopamine signals? Brain Res Rev 58(2):322–339. https://doi.org/10.1016/j.brainresrev.2007.10.007 PubMedCrossRef

Remple MS, Bradenham CH, Kao CC, Charles PD, Neimat JS, Konrad PE (2011) Subthalamic nucleus neuronal firing rate increases with Parkinson’s disease progression. Mov Disord 26(9):1657–1662. https://doi.org/10.1002/mds.23708 PubMedPubMedCentralCrossRef

Rommelfanger KS, Wichmann T (2010) Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat 4:139. https://doi.org/10.3389/fnana.2010.00139 PubMedPubMedCentralCrossRef

Rylander D, Bagetta V, Pendolino V, Zianni E, Grealish S, Gardoni F, Di Luca M, Calabresi P, Cenci MA, Picconi B (2013) Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism. Proc Natl Acad Sci USA 110(46):E4375-4384. https://doi.org/10.1073/pnas.1311187110 CrossRef

Sgambato-Faure V, Cenci MA (2012) Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson’s disease. Prog Neurobiol 96(1):69–86. https://doi.org/10.1016/j.pneurobio.2011.10.005 PubMedCrossRef

Sharott A, Vinciati F, Nakamura KC, Magill PJ (2017) A population of indirect pathway striatal projection neurons is selectively entrained to parkinsonian beta oscillations. J Neurosci 37(41):9977–9998. https://doi.org/10.1523/JNEUROSCI.0658-17.2017 PubMedPubMedCentralCrossRef

Smith Y, Galvan A, Ellender TJ, Doig N, Villalba RM, Huerta-Ocampo I, Wichmann T, Bolam JP (2014) The thalamostriatal system in normal and diseased states. Front Syst Neurosci 8:5. https://doi.org/10.3389/fnsys.2014.00005 PubMedPubMedCentralCrossRef

Spanne A, Jorntell H (2013) Processing of multi-dimensional sensorimotor information in the spinal and cerebellar neuronal circuitry: a new hypothesis. PLoS Comput Biol 9(3):e1002979. https://doi.org/10.1371/journal.pcbi.1002979 PubMedPubMedCentralCrossRef

Stefani A, Peppe A, Pierantozzi M, Galati S, Moschella V, Stanzione P, Mazzone P (2009) Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian–parafascicularis complex. Brain Res Bull 78(2–3):113–118. https://doi.org/10.1016/j.brainresbull.2008.08.007 PubMedCrossRef

Suarez LM, Solis O, Carames JM, Taravini IR, Solis JM, Murer MG, Moratalla R (2014) l-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatry 75(9):711–722. https://doi.org/10.1016/j.biopsych.2013.05.006 PubMedCrossRef

Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R (2016) l-DOPA oppositely regulates synaptic strength and spine morphology in D1 and D2 striatal projection neurons in dyskinesia. Cereb Cortex 26(11):4253–4264. https://doi.org/10.1093/cercor/bhw263 PubMedPubMedCentralCrossRef

Suarez LM, Alberquilla S, Garcia-Montes JR, Moratalla R (2018) Differential synaptic remodeling by dopamine in direct and indirect striatal projection neurons in Pitx3−/− mice, a genetic model of Parkinson’s disease. J Neurosci. https://doi.org/10.1523/JNEUROSCI.3184-17.2018 PubMedCrossRef

Surmeier DJ, Graves SM, Shen W (2014) Dopaminergic modulation of striatal networks in health and Parkinson’s disease. Curr Opin Neurobiol 29:109–117. https://doi.org/10.1016/j.conb.2014.07.008 PubMedPubMedCentralCrossRef

Sutton AC, O’Connor KA, Pilitsis JG, Shin DS (2015) Stimulation of the subthalamic nucleus engages the cerebellum for motor function in parkinsonian rats. Brain Struct Funct 220(6):3595–3609. https://doi.org/10.1007/s00429-014-0876-8 PubMedCrossRef

Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Wang SS, Ziman N, Ostrem JL, San Luciano M, Galifianakis NB, Starr PA (2016) Gamma oscillations in the hyperkinetic state detected with chronic human brain recordings in Parkinson’s disease. J Neurosci 36(24):6445–6458. https://doi.org/10.1523/JNEUROSCI.1128-16.2016 PubMedPubMedCentralCrossRef

Tamte M, Brys I, Richter U, Ivica N, Halje P, Petersson P (2016) Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia. J Neurophysiol 115(3):1713–1729. https://doi.org/10.1152/jn.00868.2015 PubMedPubMedCentralCrossRef

Tanimura A, Pancani T, Lim SAO, Tubert C, Melendez AE, Shen W, Surmeier DJ (2017) Striatal cholinergic interneurons and Parkinson’s disease. Eur J Neurosci. https://doi.org/10.1111/ejn.13638 PubMedCrossRef

te Woerd ES, Oostenveld R, Bloem BR, de Lange FP, Praamstra P (2015) Effects of rhythmic stimulus presentation on oscillatory brain activity: the physiology of cueing in Parkinson’s disease. Neuroimage Clin 9:300–309. https://doi.org/10.1016/j.nicl.2015.08.018 CrossRef

Tepper JM, Tecuapetla F, Koos T, Ibanez-Sandoval O (2010) Heterogeneity and diversity of striatal GABAergic interneurons. Front Neuroanat 4:150. https://doi.org/10.3389/fnana.2010.00150 PubMedPubMedCentralCrossRef

Testini P, Min HK, Bashir A, Lee KH (2016) Deep brain stimulation for Tourette’s syndrome: the case for targeting the thalamic centromedian–parafascicular complex. Front Neurol 7:193. https://doi.org/10.3389/fneur.2016.00193 PubMedPubMedCentralCrossRef

Thiele SL, Chen B, Lo C, Gertler TS, Warre R, Surmeier JD, Brotchie JM, Nash JE (2014) Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiol Dis 71:334–344. https://doi.org/10.1016/j.nbd.2014.08.006 PubMedPubMedCentralCrossRef

Tseng KY, Kasanetz F, Kargieman L, Riquelme LA, Murer MG (2001) Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 21(16):6430–6439PubMedCrossRef

Villalba RM, Wichmann T, Smith Y (2014) Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson’s disease. Brain Struct Funct 219(1):381–394. https://doi.org/10.1007/s00429-013-0507-9 PubMedCrossRef

Wang XJ (2010) Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev 90(3):1195–1268. https://doi.org/10.1152/physrev.00035.2008 PubMedPubMedCentralCrossRef

Whittington MA, Traub RD, Jefferys JG (1995) Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 373(6515):612–615. https://doi.org/10.1038/373612a0 PubMedCrossRef

Wu Y, Richard S, Parent A (2000) The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 38(1):49–62PubMedCrossRef

Yamanaka K, Hori Y, Minamimoto T, Yamada H, Matsumoto N, Enomoto K, Aosaki T, Graybiel AM, Kimura M (2017) Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events. J Neural Transm (Vienna). https://doi.org/10.1007/s00702-017-1713-z CrossRef

Yang Y, Wang H, Hu J, Hu H (2017) Lateral habenula in the pathophysiology of depression. Curr Opin Neurobiol 48:90–96. https://doi.org/10.1016/j.conb.2017.10.024 PubMedCrossRef

Zhai S, Tanimura A, Graves SM, Shen W, Surmeier DJ (2017) Striatal synapses, circuits, and Parkinson’s disease. Curr Opin Neurobiol 48:9–16. https://doi.org/10.1016/j.conb.2017.08.004 PubMedPubMedCentralCrossRef

Title: On the neuronal circuitry mediating l-DOPA-induced dyskinesia
Authors: M. Angela Cenci
Henrik Jörntell
Per Petersson
Publication date: 01-08-2018
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 8/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-018-1886-0

At a glance: The STEP trials

Springer Medicine

On the neuronal circuitry mediating l-DOPA-induced dyskinesia

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse

Glutamatergic mechanisms in l-DOPA-induced dyskinesia and therapeutic implications

Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers

Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities

The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective

Impulse control disorders in Parkinson’s disease